| Product Name | MF | CAS | Details |
|---|
| (Rac)-BAY1238097 | C25H33N5O3 | 1564268-19-4 | Details |
| GSK1379725A | C23H23FN6O3 | 1802251-00-8 | Details |
| Sirt2-IN-1 | C28H27N7O2S2 | 1862238-00-3 | Details |
| HJB97 | C26H28N8O3 | 2093391-24-1 | Details |
| INCB054329 | C19H16N4O3 | 1628607-64-6 | Details |
| CF53 | C24H25N7O2 | 1808160-52-2 | Details |
| SIRT5 inhibitor 1 | C31H39FN6O6S2 | 2166487-21-2 | Details |
| PKC-theta inhibitor | C20H25F3N6O3 | 736048-65-0 | Details |
| SGC-iMLLT | C22H24N6O | 2255338-25-9 | Details |
| Nudifloramide | C7H8N2O2 | 701-44-0 | Details |
| BI-9321 trihydrochloride | C22H22ClFN4 | 2387510-87-2 | Details |
| MRK-740 | C25H32N6O3 | 2387510-80-5 | Details |
| UBCS039 | C16H13N3 | 358721-70-7 | Details |
| PIN1 inhibitor API-1 | C15H13F3N6O2 | 680622-70-2 | Details |
| GSK467 | C17H13N5O2 | 1628332-52-4 | Details |
| TCS 21311 | C27H25F3N4O4 | 1260181-14-3 | Details |
| GNE-049 | C27H32F2N6O2 | 1936421-41-8 | Details |
| DCP-LA | C20H36O2 | 28399-31-7 | Details |
| DCPLA-ME | C21H38O2 | 56687-67-3 | Details |
| EB-47 dihydrochloride | C24H28ClN9O6 | 1190332-25-2 | Details |
| BYK204165 | C15H12N2O2 | 1104546-89-5 | Details |
| GNE-781 | C27H33F2N7O2 | 1936422-33-1 | Details |
| GeA-69 | C20H16N2O | 2143475-98-1 | Details |
| JFD00244 | C30H26N2O4 | 96969-83-4 | Details |
| Valemetostat tosylate | C33H42ClN3O7S | 1809336-93-3 | Details |
| UNC0224 | C26H43N7O2 | 1197196-48-7 | Details |
| UNC0321 | C27H45N7O3 | 1238673-32-9 | Details |
| EZM 2302 | C29H37ClN6O5 | 1628830-21-6 | Details |
| E-7386 | C39H48FN9O4 | 1799824-08-0 | Details |
| EBI-2511 | C34H48N4O4 | 2098546-05-3 | Details |
| CBP/EP300-IN-1 | C23H23FN2O5 | 2443789-32-8 | Details |
| Y06036 | C16H15BrN2O5S | 1832671-96-1 | Details |
| Y06137 | C27H32N4O2 | 2226534-49-0 | Details |
| EHMT2-IN-2 | C21H22N6O | 2230850-47-0 | Details |
| BRD7-IN-1 | C22H27ClN4O3 | 2448414-48-8 | Details |
| MT1 | C54H66Cl2N10O9S2 | 2060573-82-0 | Details |
| ZL0420 | C16H16N4O2 | 2230496-80-5 | Details |
| NCGC00247743 | C24H29N3O2 | 1435192-04-3 | Details |
| BAY1238097 | C25H33N5O3 | 1564268-08-1 | Details |
| (R)-BAY1238097 | C25H33N5O3 | 1564269-85-7 | Details |
| GNA002 | C42H55NO8 | 1385035-79-9 | Details |
| A-395 | C26H35FN4O2S | 2089148-72-9 | Details |
| JNJ-64619178 | C22H23BrN6O2 | 2086772-26-9 | Details |
| IACS-9571 hydrochloride | C32H43ClN4O8S | 2319611-93-1 | Details |
| MOZ-IN-2 | C17H13FN4O3S | 2055397-88-9 | Details |
| BET bromodomain inhibitor | C24H20ClN5O2 | 1505453-59-7 | Details |
| CMPD101 | C24H21F3N6O | 865608-11-3 | Details |
| T-3775440 hydrochloride | C18H23ClN4O | 1422535-52-1 | Details |
| Fasudil Hydrochloride | C14H18ClN3O2S | 105628-07-7 | Details |
| PROTAC Sirt2 Degrader-1 | C40H40N10O8S2 | 2098487-75-1 | Details |
| PF-06726304 | C22H21Cl2N3O3 | 1616287-82-1 | Details |
| Seclidemstat | C20H23ClN4O4S | 1423715-37-0 | Details |
| GSK2807 Trifluoroacetate | C21H33F3N8O7 | 2245255-66-5 | Details |
| QC6352 | C24H25N3O2 | 1851373-36-8 | Details |
| CAY10602 | C22H15FN4O2S | 374922-43-7 | Details |
| SRT 1720 | C25H23N7OS | 925434-55-5 | Details |
| Niraparib hydrochloride | C19H20N4O | 1038915-64-8 | Details |
| Niraparib (R-enantiomer) | C19H20N4O | 1038915-58-0 | Details |
| Delcasertib | C120H199N45O34S2 | 949100-39-4 | Details |
| SB-218078 | C24H15N3O3 | 135897-06-2 | Details |
| BAY-299 | C25H23N3O4 | 2080306-23-4 | Details |
| GSK8573 | C20H21NO3 | 1693766-04-9 | Details |
| R 59-022 | C27H26FN3OS | 93076-89-2 | Details |
| Bisindolylmaleimide X hydrochloride | C26H25ClN4O2 | 145317-11-9 | Details |
| ICAM-1-IN-1 | C15H11BrN2O2S | 251994-14-6 | Details |
| KDM5A-IN-1 | C15H22N4O2 | 1905481-36-8 | Details |
| A-196 | C18H16Cl2N4 | 1982372-88-2 | Details |
| ME0328 | C19H19N3O2 | 1445251-22-8 | Details |
| BI-7273 | C20H23N3O3 | 1883429-21-7 | Details |
| MS049 | C15H24N2O | 1502816-23-0 | Details |
| KDM5-IN-1 | C17H20N6O | 1628210-26-3 | Details |
| TP-472 | C20H19N3O2 | 2079895-62-6 | Details |
| SGC2085 | C19H24N2O2 | 1821908-48-8 | Details |
| Cl-amidine hydrochloride | C14H20Cl2N4O2 | 1373232-26-8 | Details |
| Hispidin | C13H10O5 | 555-55-5 | Details |
| AZD5153 6-Hydroxy-2-naphthoic acid | C36H41N7O6 | 1869912-40-2 | Details |
| Lin28-let-7a antagonist 1 | C31H29N5O7 | 2024548-03-4 | Details |
| TPOP146 | C27H35N3O5 | 2018300-62-2 | Details |
| GNE-272 | C22H25FN6O2 | 1936428-93-1 | Details |
| GSK9311 | C24H31N5O3 | 1923851-49-3 | Details |
| Histone Acetyltransferase Inhibitor II | C20H16Br2O3 | 932749-62-7 | Details |
| HA-100 | C13H15N3O2S | 84468-24-6 | Details |
| GSK 4027 | C17H21BrN4O | 2079896-25-4 | Details |
| GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
| D-erythro-Sphingosine | C18H37NO2 | 123-78-4 | Details |
| PBIT | C14H11NOS | 2514-30-9 | Details |
| AK-1 | C19H21N3O5S | 330461-64-8 | Details |
| Gly-Arg-Gly-Asp-Ser | C17H30N8O9 | 96426-21-0 | Details |
| 187-1, N-WASP inhibitor | C96H122N18O16 | 380488-27-7 | Details |
| Dynamin inhibitory peptide | C47H80N18O14 | 251634-21-6 | Details |
| HSDVHK-NH2 | C30H48N12O9 | 848644-86-0 | Details |
| DynaMin inhibitory peptide, myristoylated | C61H107N19O14 | 251634-22-7 | Details |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | C28H39F3N8O9 | 199807-33-5 | Details |
| Vedolizumab | 943609-66-3 | Details |
| Carbenoxolone disodium | C34H48Na2O7 | 7421-40-1 | Details |
| Cyclo(-RGDfK) | C27H41N9O7 | 161552-03-0 | Details |
| Cyclo(-RGDfK) TFA | C29H42F3N9O9 | 500577-51-5 | Details |
| Cyclo(RADfK) | C28H43N9O7 | 756500-23-9 | Details |
| iRGD peptide | C35H57N13O14S2 | 1392278-76-0 | Details |
| Gap 27 | C60H101N15O17 | 198284-64-9 | Details |
| Product Total： Product Page： | ||||
| 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 | ||||